Topic: infectious disease
The Chan Zuckerberg Biohub has unveiled an open-source platform for charting international infectious disease outbreaks in real time.
Insights into how bacteria hibernate and use metals to evade destruction by antibiotics could be useful in drug development.
MeMed raised $70 million for its immune system diagnostic for distinguishing between bacterial and viral infections, to reduce antibiotic misuse.
Using CRISPR screening, a UT Southwestern team found an interferon-stimulated gene that's key to resisting Zika.
An engineered form of a naturally occurring molecule can penetrate hard-to-kill, Gram-negative bacteria.
China’s Jacobio Pharmaceuticals raised $55 million to advance a cancer drug into the clinic, conduct preclinical work and ramp up its R&D pipelines.
Norovirus and rotavirus get transmitted to humans through "virus clusters" that exacerbate the spread of the illnesses.
GlaxoSmithKline is close to ending a six-decade drought in relapse-preventing therapies for Plasmodium vivax—one of the most common forms of malaria.
New HIV treatments could target a molecule called IP6 to render the virus vulnerable to the immune system.